宝馨科技(002514.SZ):转让方与盐高新签署股权转让事宜之终止协议
格隆汇 9 月 7日丨宝馨科技(002514.SZ)公布,转让方与盐高新于2020年9月7日签署了《陈东、汪敏、朱永福、苏州永福投资有限公司和盐城高新区投资集团有限公司股权转让事宜之终止协议》。
因未获得江苏省国有资产监督管理委员会的批准,股权转让事宜终止。经转受让双方协商一致,同意解除上述《股权转让框架协议》,终止本次收购,因股权及控制权转让签订的一系列协议终止并解除。转受让双方于2020年9月7日签署了《陈东、汪敏、朱永福、苏州永福投资有限公司和盐城高新区投资集团有限公司股权转让事宜之终止协议》,转让方前期收到的5000万元人民币履约保证金予以退还给盐高新。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.